Paolo Maximo Francisco Borromeo

Mr. Paolo Borromeo was the Alternate Director to Mr Fernando Miranda Zobel de Ayala since 15 June 2020 and has been re-designated as the Alternate Director of Mr Cezar Peralta Consing on 8 August 2021.

Mr. Paolo Borromeo has been the Head of Strategic and Business Development of Ayala Corporation since July 2012, where he oversees the overall corporate planning process, portfolio strategy, group-wide innovation projects, data and analytics, digital initiatives, new business development and special projects.

He has been a member of the Ayala Corporation Management Committee and the Ayala Group Management Committee since September 2014 and serves on the boards of other Ayala companies including AC Energy International, AC Industrial Technology Holdings Inc., AC Ventures Holding Corp., HCX Technology Partners Inc. and Ayala International Holdings Limited.

Mr. Paolo Borromeo also leads Ayala Corporation’s healthcare businesses and is the President and CEO of Ayala Healthcare Holdings, Inc., Zapfam, Inc (FamilyDoc), and Healthway Philippines Inc.; the Chairman of IE Medica and MedEthix; and the Vice Chairman of the Generika Group of Companies. Prior to joining Ayala Corporation, Mr. Paolo Borromeo was a Principal at Booz & Company, a global strategy consulting firm based in San Francisco, California, USA.

Mr. Paolo Borromeo holds a Master in Business Administration from Wharton School at the University of Pennsylvania.